Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
TriNet Group, Inc. (NASDAQ:TNET) Director Paul Edward Chamberlain sold 600 shares of common stock on November 6, 2025, at a price of $57.81, for a total transaction value of $34,686. The transaction occurred as the stock trades near its 52-week low of $54.33, with shares currently at $54.52. According to InvestingPro analysis, TriNet appears undervalued compared to its Fair Value assessment.
Following the transaction, Chamberlain directly owns 37,840 shares of TriNet Group, Inc. The sale was executed under a pre-arranged 10b5-1 trading plan established on November 26, 2024. Despite the director’s sale, InvestingPro data shows management has been aggressively buying back shares, with the company offering a 2.02% dividend yield. TriNet’s stock has declined 32.93% over the past six months, though it remains profitable with a P/E ratio of 20.76. For deeper insights on TNET and 1,400+ other stocks, check out the comprehensive Pro Research Reports available on InvestingPro.
In other recent news, TriNet Group Inc. reported impressive financial results for the third quarter of 2025. The company achieved earnings per share of $1.11, significantly surpassing the projected $0.78. TriNet also reported revenue of $1.23 billion, far exceeding the anticipated $261.84 million. These results highlight a strong performance for the company during this period. Additionally, despite the positive earnings report, the stock price remained stable. Analysts and investors will likely keep a close eye on TriNet’s future performance following these robust financial outcomes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.